By Dhirendra TripathiInvesting.com – Johnson & Johnson (NYSE:JNJ) stock was up 1.2% in Wednesday’s premarket trading as the company raised its full-year guidance for sales and...
By Dhirendra TripathiInvesting.com – Shares of vaccine makers rose Tuesday after Fox News anchors endorsed vaccinations amid a growing outbreak of coronavirus infections connected...
By Dhirendra TripathiInvesting.com – Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX) stocks rose in a broad market selloff fueled by worries that the rapidly-spreading Delta...
After its more than 450% surge during 2020, the meteoric rally in Moderna (NASDAQ:MRNA) shares continues this year. The gains—propelled by the biotech's breakthrough vaccine...
When is Moderna’s earnings date?The Moderna (NASDAQ:MRNA) earnings release date is scheduled for 6 May 2021. The results will cover the group's quarter one (Q1) financial...
Stocks on Wall Street slipped on Friday, with the major averages all ending down, but within sight of their recent records amid ongoing optimism over the economic recovery.The...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Strong Buy | Buy |
| Summary | Neutral | Strong Sell | Neutral | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.64 | 0.00 | 0.00 | 0.00 | 0.00% | 2.50K | Lagos | |||
| 4.81 | 4.81 | 4.81 | 0.000 | 0.00% | 506.09K | Lagos | |||
| 8.90 | 8.90 | 8.90 | 0.00 | 0.00% | 19.31K | Lagos | |||
| 3.10 | 3.10 | 3.10 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.48 | 0.00 | 0.00 | +0.03 | +6.67% | 1.32M | Lagos | |||
| 0.24 | 0.00 | 0.00 | +0.01 | +4.35% | 955.01K | Lagos | |||
| 0.65 | 0.00 | 0.00 | 0.00 | 0.00% | 12.46K | Lagos | |||
| 1.24 | 1.35 | 1.23 | -0.12 | -8.89% | 10.70M | Lagos | |||
| 1.54 | 1.54 | 1.54 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 4.70 | 4.70 | 4.70 | +0.090 | +1.95% | 413.52K | Lagos | |||
| 50.10 | 50.10 | 50.10 | -2.85 | -5.38% | 467.00 | Lagos | |||
| 1.25 | 1.25 | 1.25 | +0.060 | +5.04% | 27.51K | Lagos | |||
| 0.78 | 0.00 | 0.00 | 0.00 | 0.00% | 213.00 | Lagos | |||
| 6.70 | 6.70 | 6.70 | +0.55 | +8.94% | 150.00 | Lagos | |||
| 1.10 | 1.10 | 1.08 | +0.02 | +1.85% | 5.24M | Lagos |
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.